Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1352543.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ursodeoxycholic acid, 10 to 20 mg/kg per day, was administered for 1 year to 22 patients with cystic fibrosis and chronic cholestasis, resulting in significantly improved liver enzyme values. However, evidence of cholestasis continued, as shown by the pattern of alkaline phosphatase isoenzymes.
Medical subject headings
- Cholestasis
- Cystic Fibrosis
- Liver
- Ursodeoxycholic Acid